Skip to main content
Clinical Cardiology logoLink to Clinical Cardiology
. 2009 Nov 12;32(10):584–587. doi: 10.1002/clc.20660

Is There a Link Between Gastroesophageal Reflux Disease and Atrial Fibrillation?

Jeffrey S Kunz 1,, Brian Hemann 1, J Edwin Atwood 1, Jeffrey Jackson 2, Timothy Wu 3, Carolyn Hamm 3
PMCID: PMC6653088  PMID: 19911354

Abstract

Background

Previous studies suggest a potential association between gastroesophageal reflux disease (GERD) and atrial fibrillation.

Objective

To explore the potential association between GERD and atrial fibrillation.

Materials and Methods

This was a retrospective study created from a database containing all health care encounters for patients who received ambulatory care in the National Capitol Area military health care system between January 1, 2001 and October 28, 2007. The study population included all subjects at least 18 years of age (n = 163 627). Our primary outcomes of interest were International Classification of Diseases, Ninth Revision (ICD‐9) diagnoses of atrial fibrillation and GERD.

Results

Among 163 627 patients, 7992 (5%) had atrial fibrillation and 47 845 (29%) had GERD. The presence of GERD increased the relative risk (RR) of a diagnosis of atrial fibrillation (RR: 1.39, 95% confidence interval [CI]: 1.33–1.45). In sensitivity analyses, this relationship persisted after adjustment for cardiovascular disease risk factors (RR: 1.19, 95% CI: 1.13–1.25) and diagnoses known to be strongly associated with atrial fibrillation (RR: 1.08, 95% CI: 1.02–1.13).

Conclusions

The presence of GERD is associated with an increased risk of a diagnosis of atrial fibrillation. Copyright © 2009 Wiley Periodicals, Inc.

Full Text

The Full Text of this article is available as a PDF (94.7 KB).

References

  • 1. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006; 8: 651–745. [DOI] [PubMed] [Google Scholar]
  • 2. Shaheen NJ, Hansen RA, Morgan DR, et al. The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol 2006; 101: 2128–2138. [DOI] [PubMed] [Google Scholar]
  • 3. Gillinov AM, Rice TW. Prandial atrial fibrillation: off‐pump pulmonary vein isolation with hiatal hernia repair. Ann Thorac Surg 2004; 78: 1836–1838. [DOI] [PubMed] [Google Scholar]
  • 4. Gordon J, Saleem SM, Ngaage DL, Thorpe JA. Swallow syncope associated with paroxysmal atrial fibrillation. Eur J Cardiothorac Surg 2002; 21: 587–590. [DOI] [PubMed] [Google Scholar]
  • 5. Nakamura H, Nakaji G, Shimazu H, et al. Case of paroxysmal atrial fibrillation improved after the administration of proton pump inhibitor for associated reflux esophagitis. Fukuoka Igaku Zasshi 2007; 98: 270–276. [PubMed] [Google Scholar]
  • 6. Stollberger C, Finsterer J. Treatment of esophagitis/vagitis‐induced paroxysmal atrial fibrillation by proton‐pump inhibitors. J Gastroenterol 2003; 38: 1109. [DOI] [PubMed] [Google Scholar]
  • 7. Hosmer DW, Lemeshow S. In: Applied Logistic Regression. 2nd ed., Ch. 1.2 New York, NY: John C. Wiley & Sons; 2000. [Google Scholar]
  • 8. Box GEP, Tidwell PW. Transformation of the independent variables. Technometrics 1962; 4: 531–550. [Google Scholar]
  • 9. Schauerte P, Scherlag BJ, Pitha J, et al. Catheter ablation of cardiac autonomic nerves for prevention of vagal atrial fibrillation. Circulation 2000; 102: 2774–2780. [DOI] [PubMed] [Google Scholar]
  • 10. Chen PS, Tan AY. Autonomic nerve activity and atrial fibrillation. Heart Rhythm 2007; 4: S61–S64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Bajwa A, Hollerbach S, Kamath MV, et al. Neurocardiac response to esophageal electric stimulation in humans: effects of varying stimulation frequencies. Am J Physiol 1997; 272: R896–R901. [DOI] [PubMed] [Google Scholar]
  • 12. Ramet J. Cardiac and respiratory reactivity to gastroesophageal reflux: experimental data in infants. Biol Neonate 1994; 65: 240–246. [DOI] [PubMed] [Google Scholar]
  • 13. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997; 96: 1180–1184. [DOI] [PubMed] [Google Scholar]
  • 14. Siu CW, Lau CP, Tse HF. Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion. Am J Cardiol 2003; 92: 1343–1345. [DOI] [PubMed] [Google Scholar]
  • 15. Young‐Xu Y, Jabbour S, Goldberg R, et al. Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease. Am J Cardiol 2003; 92: 1379–1383. [DOI] [PubMed] [Google Scholar]
  • 16. Pappone C, Oral H, Santinelli V, et al. Atrio‐esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation. Circulation 2004; 109: 2724–2726. [DOI] [PubMed] [Google Scholar]
  • 17. Weigl M, Gschwantler M, Gatterer E, Finsterer J, Stollberger C. Reflux esophagitis in the pathogenesis of paroxysmal atrial fibrillation: results of a pilot study. South Med J 2003; 96: 1128–1132. [DOI] [PubMed] [Google Scholar]
  • 18. Gerson LB, Friday K, Triadafilopoulos G. Potential relationship between gastroesophageal reflux disease and atrial arrhythmias. J Clin Gastroenterol 2006; 40: 828–832. [DOI] [PubMed] [Google Scholar]
  • 19. Bunch TJ, Packer DL, Jahangir A, et al. Long‐term risk of atrial fibrillation with symptomatic gastroesophageal reflux disease and esophagitis. Am J Cardiol 2008; 102: 1207–1211. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES